Trials / Recruiting
RecruitingNCT06488742
The Efficacy of 3% Kanuka Oil Versus 1% Hydrocortisone Cream in Patients With Atopic Dermatitis
Efficacy of 3% Kanuka Oil Versus 1% Hydrocortisone Cream in the Treatment of Patients With Mild Atopic Dermatitis
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Nexgen Dermatologics, Inc. · Industry
- Sex
- All
- Age
- 12 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
Atopic dermatitis is a common disease affecting millions worldwide. A common associated symptom in this population is pruritus. We seek to investigate the use of an natural, over-the-counter cosmeceutical to help this population
Detailed description
There are many treatment options available for atopic dermatitis yet many patients still suffer from the underlying symptomatology. It is important to explore other treatment alternatives to help this population.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | 3% kanuka oil | To assess the efficacy in patients with mild atopic dermatitis, 3% kanuka oil will be applied twice a day for 28 days. 3% kanuka oil is a naturally occurring extract from the kanuka tree and is considered an over-the-counter agent. |
Timeline
- Start date
- 2023-11-01
- Primary completion
- 2024-12-10
- Completion
- 2025-03-20
- First posted
- 2024-07-05
- Last updated
- 2024-07-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06488742. Inclusion in this directory is not an endorsement.